Department of Metabolism & Endocrinology, Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Japan.
Department of Metabolism & Endocrinology, Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Japan
BMJ Open Diabetes Res Care. 2021 Apr;9(1). doi: 10.1136/bmjdrc-2020-001923.
Preventing the development and progression of diabetic microvascular complications through optimal blood glucose control remains an important challenge. Whether metrics based on continuous glucose monitoring are useful for the management of diabetic microvascular complications is not entirely clear.
This is an exploratory analysis of an ongoing prospective, multicenter, 5-year follow-up observational study. Study participants included 999 outpatients with type 2 diabetes who underwent continuous glucose monitoring at baseline. Associations between continuous glucose monitoring-derived metrics and the severity of diabetic retinopathy or albuminuria were investigated using multivariable proportional odds models.
The overall prevalence of diabetic retinopathy was 22.2%. Multivariate analysis with proportional odds models demonstrated that continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy, even after adjusting for various possible risk factors. However, significant relationships were not observed after adjusting for hemoglobin A1c (HbA1c) levels. The prevalence of microalbuminuria and macroalbuminuria was 20.3% and 6.7%, respectively. Similarly, multivariate analysis demonstrated that those metrics are significantly associated with the severity of albuminuria. These relationships remained significant even after further adjusting for HbA1c levels.
Continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy or albuminuria in patients with type 2 diabetes. Thus, evaluating these metrics might possibly be useful for risk assessment of diabetic microvascular complications. UMIN000032325.
通过优化血糖控制来预防糖尿病微血管并发症的发生和进展仍然是一个重要的挑战。基于连续血糖监测的指标是否有助于糖尿病微血管并发症的管理尚不完全清楚。
这是一项正在进行的前瞻性、多中心、5 年随访观察性研究的探索性分析。研究参与者包括 999 名 2 型糖尿病门诊患者,他们在基线时进行了连续血糖监测。使用多变量比例优势模型研究了连续血糖监测衍生指标与糖尿病视网膜病变或白蛋白尿严重程度之间的关联。
糖尿病视网膜病变的总患病率为 22.2%。多变量比例优势模型分析表明,与日内和日间血糖变异性相关的连续血糖监测衍生指标与糖尿病视网膜病变的严重程度显著相关,即使在调整了各种可能的危险因素后也是如此。然而,在调整血红蛋白 A1c(HbA1c)水平后,没有观察到显著的相关性。微量白蛋白尿和大量白蛋白尿的患病率分别为 20.3%和 6.7%。同样,多变量分析表明,这些指标与白蛋白尿的严重程度显著相关。即使进一步调整了 HbA1c 水平,这些关系仍然显著。
与日内和日间血糖变异性相关的连续血糖监测衍生指标与 2 型糖尿病患者糖尿病视网膜病变或白蛋白尿的严重程度显著相关。因此,评估这些指标可能有助于评估糖尿病微血管并发症的风险。UMIN000032325。